Loading data for IRWD — first visit, this takes a few seconds.
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS: IRWD
· 即時價格 · USD
4.41
+0.14 (3.28%)
收盤價： Sep 02, 2026, 8:00 PM
4.42
+0.23%
盤後: 7:30 PM
股價、關鍵數字和最新消息，都在這一頁。
Ironwood Pharmaceuticals, Inc.（IRWD）股價、分析與資料
無可用資料
| 買價 | 3.74 |
| 市值 | 729M |
| 營收 (ttm) | 389M |
| 淨利（ttm） | 130M |
| 0.21 | |
| 0.79 | |
| 5.58 | |
| 2.94 | |
| P/B (ttm) | -4.50 |
| P/S (ttm) | 1.87 |
| 財報日期 | Feb 15, 2024 |
| 賣價 | 4.95 |
| 成交量 | 2,427,301 |
| 20 日平均成交量 | 2,228,831 |
| 開盤價 | 4.31 |
| 前收盤價 | 4.27 |
| 當日區間 | 4.26 - 4.47 |
| 52 週範圍 | 1.01 - 5.78 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 IRWD
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional...
完整的公司簡介財務表現
Ironwood Pharmaceuticals 在 2025 年的營收為 296.15M，較前一年的 351.41M 減少 -15.72%。 淨利為 24.02M，較前期增加 2,629.2%。
財務報表財報驚奇
Ironwood Pharmaceuticals 已於 Aug 6, 2026 公布季度財報：
- 營收為 $113.04M 低於預期 $0, 年增 32.62% 成長.
- 每股盈餘為 0.31 超出預期 0.03, 年增 121.43% 成長.
第 1 頁，共 2 頁